By demonstrating how Hsp90 modulates immune activation, tissue inflammation, and skin-specific immune responses in AIBDs, this section supports the broader concept of Hsp90 as a central regulator of cutaneous immunopathology - setting the stage for the subsequent focus on its role and inhibition in AD (Table 1). Here, HSP90AB1 is linked to Alzheimer disease.